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Trans-nerolidol and valencene belong to sesquiterpenes, which present a large 
group of secondary plant metabolites. In practice, we can encounter them in the food  
or perfume industry. However, they are also used in traditional Chinese medicine. 
Recently, the biological activities of sesquiterpenes, which include e.g. anti-inflammatory 
or antineoplastic activities, were studied. Doxorubicin is one of the most important 
cytostatic drugs and various ways to improve its effectiveness and reduce side effects are 
being studied. One such usage is in combination therapy with natural substances, e.g. with 
sesquiterpenes. 
The aim of this study was to test antiproliferative effects of doxorubicin,  
trans-nerolidol and valencene on ovarian cancer cell lines SK-OV-3 and A2780. We also 
assayed the possible pro-oxidant potential of doxorubicin and terpenes by measuring the 
production of ROS. In addition, we evaluated the interaction between doxorubicin and 
terpenes by quantification of combination indexes. We also studied the possible effect of 
the terpenes on the accumulation of doxorubicin in cancer cells and its distribution within 
the cells. 
Results showed the cytotoxic effects of doxorubicin, trans-nerolidol and 
valencene. Cell line A2780 was more sensitive to all tested substances. Doxorubicin in 
line SK-OV-3 and valencen in line A2780 increased ROS production. Trans-nerolidol 
acted synergistically with doxorubicin in both cell lines. Valencen had synergic effect 
only in line A2780. Trans-nerolidol increased the accumulation of doxorubicin in the cells 
of both lines. 
